The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells

Immunobiology

Volumn 195, Issue 2, 1996, Pages 172-186

  Terao, Hiroshi ^a   Harada, Mamoru ^a   Kurosawa, Shin ^a   Shinomiya, Yoshihiro ^a   Ito, Osamu ^a   Tamada, Koji ^a   Takenoyama, Mitsuhiro ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; FEMALE; MELANOMA B16; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0029813682     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80037-4     Document Type: Article

References (26)

1. HERBERMAN, R. B. 1982. NK cells and other natural effector cells. Academic Press, New York, 145 pp.
2. TRINCHIERI, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187.
3. WARNER, J. F., and G. DENNERT. 1982. Effects of a cloned cell line with NK activity on bone marrow transplants, tumor developments and metastasis in vivo. Nature 300: 31.
4. ORTALDO, J. R., and R. B. HERBERMAN. 1984. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 10: 359.
5. + and H-2-cells in metastatic processes. J. Immunol. 136: 4729.
6. SEAMAN, W. E., M. SLEISENGER, E. ERIKSSON, and G. C. KOO. 1987. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Production in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138: 4539.
7. KÄRRE, K., G. O. KLEIN, R. KIESSLING, G. KLEIN, and J. C. RODER. 1980. In vivo NK-activity and in vivo resistance to leukemia: Studies of beige, beige/nide and wildtype hosts on C57BL background. Int. J. Cancer 26: 789.
8. TALMADGE, J. E., K. M. MEYERS, D. J. PRIEUR, and J. R. STARKEY. 1980. Role of NK cells in tumour growth and metastasis in beige mice. Nature 284: 622.
9. HABU, S., H. FUKUI, K. SHIMAMURA, M. KASAI, Y. NAGAI, K. OKUMURA, and N. TAMAOKI. 1981. In vivo effects of anti-asialo-GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127: 34.
10. KUROSAWA, S., G. MATSUZAKI, M. HARADA, T. ANDO, and K. NOMOTO. 1993. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development. Eur. J. Immunol. 23: 1029.
11. KUROSAWA, S., M. HARADA, G. MATSUZAKI, Y. SHINOMIYA, H. TERAO, N. KOBAYASHI, and K. NOMOTO. 1995. Early-appearing tumor-infiltrating natural killer cells play a crucial role in the generation of anti-tumor T lymphocytes. Immunology 85: 338.
12. GREENBERG, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49: 281.
13. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer 58: 69.
14. + T lymphocytes and macrophages. J. Clin. Lab. Immunol. 18: 97.
15. HARADA, M., G. MATSUZAKI, Y. SHINOMIYA, S. KUROSAWA, O. ITO, T. OKAMOTO, M. TAKENOYAMA, H. SUMITIKA, Y. NISHIMURA, and K. NOMOTO. 1994. Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2. Cancer Immunol. Immunother. 38: 332.
16. MORRISON, L. A., A. E. LUKACHER, V. L. BRACIALE, D. P. FAN, and T. J. BRACIALE. 1986. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp. Med. 163: 903.
17. ALLEVA, D. G., C. J. BURGER, and K. D. ELGERT. 1994. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production. J. Immunol. 153: 1674.
18. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775.
19. DING, A. H., C. F. NATHAN, and D. J. STUEHR. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediate from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 125: 1589.
20. + T and NK cells. J. Exp. Med. 180: 1937.
21. pos T cells promptly produce interleukin 4 in reponse to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285.
22. ORTALDO, J. R., A. T. MASON, J. P. GERARD, L. E. HENDERSON, W. FARRAR, R. F. HOPKINS, R. B. HERBERMAN, and H. RABIN. 1984. Effects of natural and recombinant IL-2 on regulation of IFN-γ production and natural killer activity: Lack of involvement of the Tac antigen for these immunoregulatory effects. J. Immunol. 133: 779.
23. YOUNG, H. A., and J. R. ORTALDO. 1987. One-signal requirement for interferon-γ production by human large granular lymphocytes. J. Immunol. 139: 724.
24. BANCROFT, G. J., K. C. SHEEHAN, R. D. SCHREIBER, and E. R. UNANUE. 1989. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J. Immunol. 143: 127.
25. BOON, T., J. C. CEROTTINI, B. VAN DEN EYNDE, P. VAN DER BRUGGEN, and A. VAN PEL. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337.
26. KÄRRE, K., H. G. LJUNGGREN, G. PIONTEK, and R. KIESSLING. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675.